Ligand Pharmaceuticals | LGND - SCHULD

Aktienkurs
207.78
Täglich Wechseln
-0.11 -0.05%
Monatlich
-10.35%
Jährlich
98.04%
Q2 Prognose
208.92




SCHULD Veränderung Datum
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 54.6B 17M 2025-12
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 312.77M 53.52M 2025-12
Baxter International USD 9.78B 68M 2025-12
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Eli Lilly USD 42.5B 3.6M 2025-12
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Enviri Corporation USD 1.44B 3.08M 2024-12
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Glaxosmithkline GBP 17.75B 396M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 727.62M 275K 2026-03
Intrexon USD 0 13.82M 2024-06
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Ligand Pharmaceuticals USD 451.49M 494K 2025-12
MacroGenics USD 37.01M 238K 2025-09
Merck USD 49.34B 7.97B 2025-12
Pacira USD 367.66M 4.53M 2026-03
Pfizer USD 63.73B 231M 2026-03
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 39.65M 799K 2025-12